Answers are grounded in this paper and cite their sources.
Background/Aims Patients aged ≥90 years are increasingly encountered, yet remain underrepresented in studies of gastrointestinal bleeding (GIB). We aimed to characterize the clinical presentation, management, and outcomes of GIB in patients aged ≥90 years and identify factors associated with adverse outcomes. Methods We performed a retrospective cohort study of patients aged ≥90 years admitted with GIB to a community health system between January 2022 and April 2025. Outcomes were assessed. Primary outcomes were 28-day mortality, rebleeding, and intensive care unit (ICU) admission. Univariable logistic regression was used to evaluate factors associated with adverse outcomes. Results A total of 122 patients were included in the study (median age, 92 years; 37.7% female). Overall, 104 of the 122 patients (85.2%) underwent endoscopy. In-hospital mortality was 0.8%, and 28-day mortality was 8.2%. Rebleeding and ICU admission occurred in 16.4% and 5.7% of patients, respectively. Higher blood urea nitrogen levels at presentation were associated with increased odds of rebleeding (odds ratio [OR], 1.02; 95% confidence interval [CI], 1.00–1.04; p =0.02) and ICU admission (OR, 1.03; 95% CI, 1.00–1.06; p =0.03). Conclusions Among patients aged 90 years and older hospitalized with GIB, short-term mortality was lower than the rates reported in prior cohorts. Physiological severity markers were associated with adverse outcomes, supporting risk stratification.
No takes yet. Share an insight, caveat, or question.
Sadek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: